Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory…

Overview of attention for article published in Breast Cancer Research and Treatment, September 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy: 1 policy source

facebook: 2 Facebook pages

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Policy documents Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Early and locally advanced breast cancer: diagnosis and management : J: Neoadjuvant treatment

Cited by National Institute for Health and Care Excellence on 03 Jul 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.